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Summary
The crystal structure of a recombinant mouse single
chain CD8ab ectodomains at 2.4 A˚ resolution reveals
paired immunoglobulin variable region-like domains
with a striking resemblance to CD8aa in size, shape,
andsurfaceelectrostatic potential of complementarity-
determining regions (CDR), despite <20% sequence
identity between the CD8a and CD8b subunits. Unlike
the CD8a subunit(s) in the heterodimer or homodimer,
the CDR1 loop of CD8b tilts away from its correspond-
ing CDR2 and CDR3 loops. Consistent with this obser-
vation, independent mutational studies reveal that
alanine substitutions of residues in the CDR1 loop of
CD8b have no effect on CD8ab coreceptor function,
whereas mutations in CD8b CDR2 and CDR3 loops
abolish CD8ab coreceptor activity. The implications
of these findings and additional CD8amutational stud-
ies for CD8ab- versus CD8aa-MHCI binding are dis-
cussed.
Introduction
CD8 plays a critical role in cytolytic T lymphocytes. Si-
multaneous engagement of a single peptide-MHC class
I (pMHCI) complex by a T cell receptor (TCR) and CD8 via
a bidentate attachment to an MHC class I molecule on
target cells (or antigen-presenting cells) is required for
optimal T cell stimulation (Connolly et al., 1990; Salter
et al., 1990). In the absence of CD8/pMHCI interaction,
MHC class I-restricted immune responses, including
cytokine production and cytotoxic effector function,
are selectively hampered (Crooks and Littman, 1994;
Fung-Leung et al., 1991; Nakayama et al., 1994). Thus,
CD8 functions as a coreceptor of the TCR to coordinate
antigen-specific recognition.
CD8 is expressed either as a CD8ab heterodimer or
a CD8aa homodimer on the T cell surface (Carrasco
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Konno et al., 2002; Moebius et al., 1991; Terry et al.,
1990). Although both dimers can serve as a coreceptor
for T cell activation and differentiation, they are different
in several aspects. For example, the cellular distributions
of CD8aa and CD8ab are distinct and their ligand binding
partners are unique. While CD8ab is expressed primarily
on the surface of TCRab+ thymocytes and peripheral
T cells, CD8aa exhibits a much broader tissue expres-
sion pattern (Norment and Littman, 1988; Panaccio
et al., 1987; Shiue et al., 1988; Torres-Nagel et al., 1992).
CD8aa is found on certain peripheral TCRgd+ T cells,
a subset of dendritic cells (DC) and NK1.1+ T cells, as
well as on a large fraction of intestinal intraepithelial lym-
phocytes (including TCRab+ T cells expressing CD8ab+
or CD4+, as well as double-negative [DN] T cells and
even TCRgd+ T cells) (Gangadharan and Cheroutre,
2004; Hayday et al., 2001). In addition, both CD8aa and
CD8ab interact with classical MHCIa molecules with sim-
ilar affinity. CD8aa also binds to the nonclassical MHCIb
molecule, TL, with greater affinity than to classical MHCI
molecules, suggesting that the homodimer may mediate
different function(s) other than coreceptor (Leishman
et al., 2001; Madakamutil et al., 2004; Weber et al., 2002).
Furthermore, CD8ab and CD8aa have different effi-
ciency in enhancing antigen presentation. The extracel-
lular domain of each CD8a and CD8b subunit consists of
an immunoglobulin (Ig)-like domain and a stalk region of
30–45 amino acids in length (reviewed in Zamoyska,
1994). Both the cytoplasmic tail and the extracellular
fragment of the CD8b subunit have been implicated in
the molecular process that makes CD8ab a more sensi-
tive coreceptor than CD8aa (Bosselut et al., 2000;
Luescher et al., 1995; Renard et al., 1996; Wheeler
et al., 1992; Witte et al., 1999; Wong et al., 2003). It has
been suggested that palmitoylation of a cysteine residue
in the cytoplasmic tail of CD8b during T cell activation fa-
cilitates CD8ab heterodimers partition into lipid rafts and
their association with the CD3 component of TCR com-
plexes (Arcaro et al., 2001). The association of p56lck
with the cytoplasmic domain of CD8a and the specific
enzymatic activity of p56lck was augmented by CD8b
(Irie et al., 1995). Furthermore, the O-linked glycans as-
sociated with the membrane-proximal portion of CD8b
stalk region exhibit a differentiation-dependent sialyla-
tion pattern that may modulate the intrinsic activity
of CD8ab during the transition from double-positive
(CD4+CD8+) to single-positive (CD8+) thymocytes (Merry
et al., 2003; Moody et al., 2001; Priatel et al., 2000). In
studies of CD8 ectodomain chimeric molecules, intro-
duction of the CD8b stalk region is sufficient to confer
CD8ab-like coreceptor efficiency to the CD8aa homo-
dimer (Wong et al., 2003).
We had previously expressed the Ig-like domains of
CD8 appended to a leucine zipper (CD8aa-LZ and
CD8ab-LZ) in the CHO-Lec3.2.8.1 cell system and ob-
tained a crystal complex of mCD8aa/H-2Kb (Kern et al.,
1999). In addition, structures of complexes of human
CD8aa with HLA-A2 and mouse CD8aa with the non-
classical MHC molecule, TL, were obtained (Gao et al.,
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bind classical and nonclassical MHC class I in an asym-
metric fashion, with the ‘‘top’’ CD8a1 subunit sitting be-
neath the MHCI a2 domain and the ‘‘bottom’’ CD8a2
subunit making fewer MHCI contacts. In contrast, the
structures of CD8ab or CD8ab in complex with MHCI
have been difficult to obtain. In the current study, we
have designed, expressed, and crystallized a single chain
mouse CD8ab Ig-like domains, termed scmCD8ab, pro-
duced in the CHO-Lec3.2.8.1 cell system. This mCD8ab
crystal structure allows comparison of the architectural
details of CD8aa and CD8ab proteins. Independent site-
directed mutational analyses of CD8ab support the in-
sights into the nature of CD8ab heterodimer binding to
MHCI derived from the crystal structure analyses.
Results
Overall Structure of Mouse CD8ab Heterodimer
A recombinant single chain mouse CD8ab, scmCD8abL29,
consisting of the CD8a Ig-like domain (residues 1–124)
connected to the CD8b Ig-like domain (residues 1–115)
via a 29 amino acid linker peptide was crystallized as
thin needles at pH 8.5. The structure of scmCD8abL29
was determined by X-ray crystallography to 2.4 A˚ reso-
lution by molecular replacement by use of the CD8a pro-
tomer from CD8aa structure as a search model (PDB
code 1BQH). Crystallographic data and refinement sta-
tistics are listed in Table 1. In one asymmetric unit of
the crystal, there are two scmCD8abL29 chains that
are related by an improper rotation. Only seven linker
residues can be seen N-terminal to the CD8b subunit
in electron density maps, and the remaining 22 linker
residues are in disorder, presumably due to its inherent
flexibility. Therefore, it is likely that the linker in the single
chain construct does not impose any constraint on the
natural structure of the CD8ab heterodimer. The two het-
erodimers in one asymmetric unit are similar to each
other. The overall rmsd between the two dimers is
0.962 A˚. Thus, only one CD8ab dimer will be discussed
in the following structural analyses.
The overall structure of the CD8ab heterodimer is sim-
ilar to the variable domain fragment (Fv) of an antibody
(Figure 1A). The two CD8 subunits highly resemble
each other. Both belong to the V set of Ig folds (Fig-
ure 1B; Harpaz and Chothia, 1994), despite the fact
that their primary sequences are only distantly related
with sequence identity less than 20% (19/122 for CD8a
or 19/115 for CD8b) (Figure 2). This structural similarity
is due to the fact that the residues forming the core
Ig-like domains are well conserved between CD8a and
CD8b, comprising the same or highly homologous
amino acids (shaded red in Figure 2). A C-CW triad, con-
sisting of a disulfide bond between the B and F strands
and a neighboring tryptophan on C strand, commonly
found in many Ig domains, is one of the conserved ele-
ments (Chothia et al., 1998). Both CD8 molecules are
also characterized by a cis-proline at the transition point
between the A strand and A0 strand and by b-bulges at
the C0 and the G strands. Moreover, the segment from
the C strand to E strand, which is the most variable re-
gion among Ig domains, has few deletions or insertions
between mCD8a and mCD8b (Figure 2). These elementstogether ensure that the structures of two CD8 subunits
have a similar overall architecture. The superimposition
of CD8a and CD8b subunits of the CD8ab heterodimer
(Figure 1B) results in a root-mean-square-deviation
(rmsd) value of only 0.97 A˚ for 79 Ca atoms from each
subunit (1.5 A˚ is the cutoff value).
The other conserved residues between the two CD8
subunits are mostly hydrophobic and located in the C,
C0, F, and G strands (shaded blue in Figure 2). They
also contribute to the similarity between the CD8ab het-
erodimer and the CD8aa homodimer, in which the two
CD8 subunits contact each other in a hand-shaking
mode with C, C0, F, and G strands from each subunit
forming the dimeric interface. Across each dimerization
interface, there are nine aromatic rings and two pyrrole
rings involved, similar to what has been described for
the interface between VH and VL domains of antibodies
(Chothia et al., 1985). The interface shape complemen-
tarities (Sc values) (Lawrence and Colman, 1993) be-
tween CD8a and CD8b in CD8ab and that between the
two CD8a subunits in CD8aa are very similar to each
other, 0.70 and 0.68, respectively. However, the buried
surface areas resulting from their dimerization are
slightly different, 1914 A˚2 in CD8ab and 2291 A˚2 in
CD8aa. The smaller buried surface of CD8ab seems to
be partly due to the opening up of the CC0-loops at the
bottom of the CD8ab interface.
There are three glycosylation sites in the CD8ab het-
erodimer, two in CD8a (on the CC0-loop and C0 0D-loop)
and one in CD8b (on the AB-loop). None of these glycans
are located in the vicinity of the MHC binding surface
(Figure 1A).
CD8a and CD8b in the Unligated CD8ab Heterodimer
The first three CD8a N-terminal residues (Lys1-Pro-Gln)
of both CD8ab heterodimers in the crystal asymmetric
Table 1. Data Collection and Refinement Statistics
Data Collection
Space group P21
Unit cell
a (A˚) 37.7
b (A˚) 92.7
c (A˚) 79.3
a (º) 90
b (º) 95.7
g (º) 90
Wavelength (A˚) 0.97910
Resolution (A˚) 50-2.4
Unique reflection 21001
Redundancy 3.5
Completeness (%) 99.3 (96.8)a
Rmerge (%) 7.0 (44.0)
a
I/s(I) 17.84 (2.07)a
Structure Refinement
Resolution range (A˚) 25-2.4
Reflections (work/test) 17795/1497
Rcrystal/Rfree (%) 24.16/29.40
Bond length (A˚)/angle (º) rms
deviation from ideal geometry
0.0092/1.9131
Protein atoms average B value (A˚2),
main chain/side chain
51.601/53.045
Protein/water/glycan atoms 3745/44/42
a Last resolution shell (2.49-2.4 A˚).
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(A) A ribbon diagram of the mCD8ab heterodimer. The CD8a subunit is colored in green and the CD8b subunit in orange. Three potentially
N-linked glycosylated asparagine residues (Asn42 and Asn70 of CD8a and Asn13 of CD8b) and one ordered N-acetylglucosamine unit attached
to Asn42 of CD8a are drawn in ball-and-stick form. This dimeric structure model is from one of two similar CD8ab dimers in one asymmetric unit
of the crystal. The observed partial linker between the C terminus of CD8a and the N terminus of CD8b of each dimer is not represented in the
drawing.
(B) A superimposition of the CD8a and CD8b subunits of mCD8ab. The Ca trace of each CD8 subunit was drawn and color-coded as in (A). Three
complementarity-determining regions (CDRs) and various loops are indicated. Part (A) and Figure 4 inset were created with Molscript (Kraulis,
1991). Part (B), Figure 4, and Figure 5E were created with GRASP (Nicholls et al., 1991).unit were disordered with no observable electron den-
sity, suggesting that the long CD8a N-terminal region
is flexible in its unligated native form (Figure 1). In the
CD8aa/Kb complex structure, the N-terminal residues
of the CD8a1 subunit, notably Lys1 and Gln3, form hy-
drogen bonds with the Kb-associated b2M, thus stabiliz-
ing the otherwise flexible N terminus and implying an im-
portant role in CD8aa binding and function (Kern et al.,
1998). The long N terminus is a unique feature of mouse
CD8a (Figure 2), which may contribute to some of the
differences in CD8 binding between mouse and other
species. Additionally, in the CD8aa/Kb complex, Arg8
on the A strand and Glu27 on the B strand of theCD8a1 subunit also form hydrogen bonds with b2M.
Since CD8b has neither the long N terminus nor the
Arg8 equivalent, potentially different interactions be-
tween CD8b and b2M could affect the CD8ab binding
mode relative to that of CD8aa.
The comparison of CD8a and CD8b also reveals some
differences in loop regions, especially complementarity-
determining regions (CDRs), which are involved in ligand
binding and expected to be structurally more variable
(Figure 1B). The CDR1s (BC loops) of the two CD8 sub-
units differ not only in their amino acid composition but
also in length (CD8b is one amino acid longer than
CD8a). As a result, the CDR1 (BC loop) of CD8b tiltsFigure 2. Protein Sequence Alignments of CD8a and CD8b
The sequences of mouse, human, and rat CD8a and mouse, human, rat, and cat CD8b were used for the alignment. The strand assignments are
based on the crystal structure of mCD8ab. The conserved residues of the Ig-like domain cores are shaded in red, and those contributing to the
dimeric interfaces are shaded in blue. The conserved cis-proline following the A-strand is highlighted in black.
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tion of mCD8aa and mCD8ab
The CD8a2 subunit of CD8aa from the crystal
complex of CD8aa/H-2Kb and the CD8a sub-
unit of mCD8abwere used for the superimpo-
sition. Each molecule is drawn as a Ca-trace,
with CD8a1 and CD8a2 of mCD8aa in blue
and pink and CD8a and CD8b of mCD8ab in
green and orange, respectively.away from CDR2 (C0C0 0 loop) and CDR3 (FG loop) (Fig-
ure 3). In addition, the CDR2 (C0C0 0 loop) of the mouse
CD8b subunit has one deletion in comparison to mouse
CD8a; as a consequence, the CDR2 loop of CD8b is di-
rected more toward the CDR3 loop, implying that the
CDR2 loop of CD8b may have greater involvement in
MHC binding than that of CD8a. Third, the non-CDR
CC0 loop of CD8b points away from the dimerization in-
terface, causing a reduction in the buried surface area in
the heterodimer surface contacts. Fourth, the C0 0D loops
are the most different in comparison of the two CD8 sub-
units, although we anticipate no significant role for that
loop in CD8 recognition function as it faces away from
the putative MHCI contact surface of CD8ab.
On the other hand, for both CD8a and CD8b, the CDR3
is unique to other V type Ig-like domain. The CDR3 re-
gion in the variable domain of an antibody or TCR usually
has a long, variable, and irregular loop, the FG loop, re-
quired for binding to antigens of diverse shape and char-
acter (Wang and Reinherz, 2002; Wilson and Stanfield,
1994). By contrast, the corresponding region of CD8
actually assumes a sharp b-turn instead. For CD8b, in
particular, this region is characterized by several resi-
dues conserved among different species, including
one proline at the tip of the b-turn (Figure 2). A proline
is commonly found at a sharp b-turn in other structures
(Richardson, 1981). CD8 does not bind antigen and
apparently has evolved to have a simple and rigid
FG-turn for MHCI binding. In the CD8aa/MHC class I
complex (Gao et al., 1997; Kern et al., 1998), the two
FG-turns of CD8aa homodimer define the center of the
CDR region binding surface as they clamp the CD-loop
of the MHCI a3 domain, thereby contributing key
CD8aa binding residues. The similar conformation of
the FG-turns of CD8a and CD8b imply that CD8ab may
bind MHCI in a manner similar to that of CD8aa.
In the CD8ab structure, the electron densities confirm
the formation of the canonical disulfide bond between B
and F strands in the CD8a Ig domain, which was also
observed in the CD8a subunits of CD8aa/Kb structure.
The CD8a buried cysteine (Cys36) on the C strand is un-
paired. It is noticeable that in CD8b, this cysteine is re-
placed by an isoleucine (Ile31), and the substitution
has no significant impact on the CD8b Ig core structure.
Collectively, these data suggest that a noncanonical
intramolecular disulfide bond between this cysteine on
the C strand and any other cysteine (Classon et al.,
1992; Kirszbaum et al., 1989) is unlikely. Another notice-
able substitution, namely replacement of CD8a Phe40
by CD8b Arg35 in the Ig-core region, is structurally com-patible since the aliphatic portion of the long side chain
is buried while the charged guanidine group of the argi-
nine is solvent exposed.
Structural Comparison between CD8ab and CD8aa
As discussed above, the structures of CD8a and CD8b
reveal very similar architectures with limited variation
in their loop regions. However, the binding partners for
CD8aa and CD8ab are not identical: CD8ab, like CD8aa,
binds to classical MHCIa molecules, but CD8aa also
binds to the nonclassical MHCIb, TL molecule quite effi-
ciently (Garcia et al., 1996; Kern et al., 1999; Weber et al.,
2002). In order to understand the structural basis for
their functional differences, a structure superimposition
of the two CD8 dimers was performed by overlaying the
CD8a2 of CD8aa onto the CD8a subunit of CD8ab (Fig-
ure 3). In general, the two CD8a subunits, including all
three CDRs (BC loop, C0C0 0 loop, and FG loop), align
well, with the major variation being in the CC0 and C0 0D
loops, both located at the bottom of the Ig domain. How-
ever, on the left side of the two dimers depicted in Fig-
ure 3, the CD8b subunit of the CD8ab heterodimer tilts
about 8º relative to the CD8a1 subunit of CD8aa so
that these two CD8 subunits are not in a good alignment
with one another except for the dimeric interface regions
and CDR3 (FG loop). The conserved conformation of the
two CDR3 loops at the center of the CD8/MHCI interac-
tion for both CD8aa and CD8ab suggest that the dimers
bind MHCI similarly. On the other hand, from our struc-
tural data, we anticipate that different elements, such
as CDR1 and CDR2 as well as the specific amino acids
in CDR3, may confer unique CD8ab/MHCI binding spe-
cificities. Figure 4 shows that the electrostatic potential
of the CDR regions of the CD8aa and CD8ab dimers are
similarly positive. This is also in agreement with a general
CD8 dimer/MHCI interaction model, in which the posi-
tively charged CDRs of CD8 clamp the negatively
charged CD-loop of the a3 domain of Kb, as has already
been observed in the CD8aa/MHCI complex structure
(Kern et al., 1998). Nevertheless, the observed variations
of the surfaces of the CD8aa and CD8ab dimers will lead
to subtle but important binding differences.
Though the dimerization interfaces of CD8aa and
CD8ab are similar, certain differences are worth noting,
especially those associated with the residues of CD8a
and CD8b on their C and C0 strands (Figure 2). For exam-
ple, the substitutions of Ser37 and Tyr55 of CD8a by
Tyr32 and Ser50 of CD8b, respectively, are complemen-
tary. In addition, the CD8b residues Lys43 and Phe45,
in lieu of CD8a Pro48 and Pro50, respectively, may
Crystal Structure of the CD8ab Heterodimer
665Figure 4. Molecular Surface Electrostatic Potential Representations of Kb, CD8aa, and CD8ab
A ribbon diagram shows the crystal structure of the mCD8aa/VSV8-Kb complex (Kern et al., 1998) (insert). The GRASP representation of H-2Kb is
in the same view as the ribbon diagram, with blue for positively and red for negatively charged surface. However, that of mCD8aa is rotated
roughly 90º about the y axis to put the MHC binding surface facing the reader. The residues Glu222 and Gln226 of the CD-loop of the Kb a3 do-
main and His60 and Asn107 of the CD8a1 subunit of CD8aa are marked on their corresponding surface for the relative positions of CDRs. The
GRASP representation of mCD8ab is presented in the same orientation as that of CD8aa. The locations of the CD8b Lys55 and Ser101 residues
on the crystal structure surface of CD8ab are marked.contribute to the reduction of the CD8ab interface rela-
tive to the CD8aa interface.
Functional Differences between the CDR1 Loops
of CD8a and CD8b
To assess the functional contribution of individual CDR
loop residues of CD8ab and CD8aa on antigen-specific
T cell activation, we established a CD8 transfection sys-
tem by using a T hybridoma recipient expressing the
N15 TCR that recognizes the VSV8 octapeptide in the
context of H-2Kb in a coreceptor-dependent manner.
As shown schematically in Figure 5A, the wild-type
CD8a, CD8b, or their variants were stably transfected
and expressed on the surface of N15 TCR-bearing T
cells. The surface expression levels of wild-type CD8a,
CD8b, or their variants on transfectants were matched
to within 2-fold difference before the functional assay.
One representative set of FACS analyses is shown in
Figure S1 (see the Supplemental Data available with
this article online). These cells were stimulated with
antigen-presenting cells (APC) loaded with varying mo-
lar concentrations of VSV8, and IL-2 production was
monitored as a measure of coreceptor activity. BecauseCD8a plus CD8b double transfectants express a mixture
of CD8aa and CD8ab molecules on the cell surface,
functional data with wild-type CD8 heterodimers lead
to difficulties in interpretation. However, we previously
identified a CD8a variant, CD8aR8A, which nearly abol-
ishes CD8aa coreceptor activity, whereas coreceptor
activity of CD8aR8Ab is similar to that of wild-type
CD8ab (Wong et al., 2003). Therefore, the CD8aR8A vari-
ant was used to investigate the contribution of individual
CD8b residues in CD8ab function.
To examine CD8b CDR1 residues, cell lines express-
ing CD8aR8A and one of three individual CD8b alanine
mutants (Ile25Ala, Leu28Ala, or Thr29Ala) were studied.
Figure 5B shows that all three cell lines exhibit compara-
ble (wone log peptide concentration reduction or less)
in their coreceptor activity to that of CD8aR8Abwt. Al-
though not shown, flow cytometric analyses of these
clones demonstrated the comparable levels of the sur-
face protein expression. Additional alanine mutations
at bSer24, bSer26, or bLys27 were all without functional
effect (data not shown). The above results are consistent
with the structural observation that the CDR1 loop of
CD8b points away from the center of the other CDR
Immunity
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(A) Schematic representation of the coreceptor activities of CD8aa or CD8ab dimers in N15 TCR transfectants. The N15 transfectants expressing
wt CD8aa, CD8ab, or their variants were stimulated with VSV8 peptide-loaded R8 APCs.
(B–D) The units of IL-2 produced upon antigen stimulation were plotted against the peptide concentration to assess their coreceptor activities.
Means and standard deviations (SD) were calculated from triplicate experiments. IL-2 production curves of the CD8b variants (B) at aa 25, 28, and
29 in the CDR1 loop, (C) at aa 53–57 in the CDR2 loop, and (D) aa 101–103 in the CDR3 loop expressed as CD8aR8Abvar.
(E) GRASP surface representation of the residues critical for CD8ab coreceptor function. The locations of the residues tested for their coreceptor
activities are marked on the crystal structure surface. The color codes for the side chains of residues affecting the coreceptor activities are
marked as following: a 1000- to 10,000-fold reduction, red; 10- to 100-fold reduction, pink; and no reduction, white.loops, unlike the CD8a CDR1 loops in the CD8a homo-
dimer, both of which interact with the pMHCI ligand
(Gao et al., 1997; Kern et al., 1998).
CDR2 and CDR3 Loops of CD8b Are Crucial for
CD8ab Coreceptor Activity
We next evaluated single alanine substitutions in the
CDR2 and CDR3 loops of CD8b in the same T cell hybrid-
oma system. The Lys55Ala in the CDR2 of CD8b muta-
tion shows a major impact on coreceptor function in
Figure 5C. In addition, the CD8b mutations Ser53Ala,Ser54Ala, and Gly56Ala produce partial loss of corecep-
tor function, while the Val57Ala mutation, located on the
C0 0 b strand of CD8b, has no effect on coreceptor func-
tion. These results are in agreement with the structural
prediction that CD8b mutations in CDR2 would have
a greater functional impact (Figure 3). Importantly, all
side chains of residues in the CD8b CDR3 region (aa
101–103) appear to play critical roles in the CD8ab/
pMHCI interaction. Alanine mutations of CD8b at Ser101
or Pro102 completely abrogated coreceptor activities,
while the mutation at Lys103 significantly reduced
Crystal Structure of the CD8ab Heterodimer
667Figure 6. The CD8aR8A/E27A/N107A Triple Variant Eliminates CD8aa Function without Affecting CD8ab Coreceptor Function
(A and B) IL-2 assays were performed in (A) on CD8aa homodimer and variants and in (B) on the CD8ab or CD8avarbwt transfectants via the N15
TCR hybridoma system as in Figure 5. The units of IL-2 produced upon antigen stimulation were plotted against the peptide concentration to
assess their coreceptor activities. Means and standard deviations (SD) were calculated from triplicate experiments.
(C) The ribbon drawing of a proposed CD8ab/Kb complex model. The inset shows potential interactions of two key residues (K55 and S101) of
CD8b with Kb. For clarity, the orientation of the model in the inset has been rotated 25º around the horizontal axis, and only main chain atoms
of residues G221 and L230 of Kb are shown. The starting point was the complex of VSV8/Kb and CD8aa (Kern et al., 1999) with superimposition of
CD8a2 in the CD8aa homodimer onto CD8a in CD8ab heterodimer. The residue Asn42 of CD8a and its linked N-acetylglucosamine unit are drawn
in ball-and-stick form to show their positions.coreceptor function (in Figure 5D). A GRASP surface
representation in Figure 5E depicted that the residues
crucial for CD8ab/Kb interaction form two discrete areas
at the center of the CD8ab surface.
Orientation of CD8ab Binding to H-2Kb
In the CD8aa/pMHCI complex, side chains of residues
from the N terminus (Lys1-Pro-Gln) and A and B strands
(Arg8 and Glu27, respectively) of CD8a1 form several
hydrogen bonds with b2M. These same residues in the
CD8a2 subunit have no contacts with the MHCI mole-
cule. We reasoned that if CD8a of the CD8ab hetero-
dimer would assume the CD8a2 position of the CD8aa
homodimer, then alanine substitutions of those residues
would not affect CD8ab coreceptor function. N15 TCR-
CD8aa transfectants expressing a single or double mu-
tant involving this region of CD8aR8A or CD8aR8A/E27A,
respectively, predictably lost most coreceptor activity
(Figure 6A). Furthermore, a triple mutant termed
CD8am3, in which residues Arg8, Glu27, and Asn107
were mutated to alanine, formed a CD8aa homodimer
devoid of functional activity. Note that the side chain
of Asn107 of CD8a1 but not CD8a2 makes contacts
with Kb in the CD8aa/Kb complex (Kern et al., 1998).
However, when CD8am3 is expressed in the form of a
CD8am3bwt heterodimer, its coreceptor activity is as ef-
ficient as the wild-type CD8ab or the CD8aR8Abwt heter-
odimer (Figure 6B). These data argue that CD8b in the
CD8ab heterodimer assumes a similar position as the
CD8a1 subunit in the CD8aa homodimer.To rule out the possibility that the side chains of other
residues on the CDR3 loop of CD8a might replace the
functional role of Asn107 through a minor positional
shift, we generated several additional CD8a triple
mutants, CD8aR8A/E27A/S106A, CD8aR8A/E27A/S108A, and
CD8aR8A/E27A/V109A. Each of these triple mutants had
comparable coreceptor activity to the wild-type CD8ab
when incorporated into the heterodimer (data not
shown). Thus, the side chains of CD8a Arg8, Glu27,
Ser106, Asn107, Ser108, and Val109 are not required
for CD8ab binding to Kb. A potential model of the
CD8ab interaction with VSV8/Kb accounting for these
functional data is offered in Figure 6C and described fur-
ther in the discussion below.
Discussion
Over the last decade, the molecular features of T cell
recognition have been established at structural level.
The nature of the clonotypic TCR/pMHC interaction
has been resolved for both CD4+ and CD8+ T lympho-
cytes (Garcia et al., 1999; Reinherz et al., 1999). In addi-
tion, the structures of the CD33g and CD33d compo-
nents of the TCR have been defined (Arnett et al.,
2004; Sun et al., 2001, 2004). The details of coreceptors
CD4 and the CD8aa homodimer and their interactions
with MHC class I and class II molecules, respectively,
were also revealed (Gao et al., 1997; Kern et al., 1998;
Wang et al., 2001). Until now, however, structural insight
into CD8ab and its pMHCI binding has been one missing
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tion machinery.
A potential clue to the difficulty in obtaining useful
CD8ab crystals is the smaller interdomain contact area
of the CD8ab Ig-like domains compared to CD8aa
(1914 A˚2 versus 2290 A˚2). Consistent with this observa-
tion, cleavage of the leucine zipper appended to the
Ig-like domains of purified recombinant CD8ab hetero-
dimers, resulting in formation of CD8aa and CD8bb ho-
modimers, implying a weak association of heterodimers
(P. Kern, J.O., and H.-C.C., unpublished results). Al-
though crystals were obtained and partially purified in
CD8ab preparation, they were not of diffraction quality,
most likely as a result of such mixed dimer formation.
Covalently attaching of CD8a and CD8b Ig-like domains
in a single chain construct undoubtedly contributed
to the current success in structural resolution of the
CD8ab Ig-like domains. As a biological correlate, de-
velopmental stage-dependent modification of CD8b
O-linked carbohydrates by St3 Gal-1 sialyltransferase
results in sialic acid capping of sites on the CD8b stalk
adjacent to its Ig-like domain (Merry et al., 2003; Moody
et al., 2001). This developmental change and associated
alteration of CD8ab MHCI binding activity during the
CD4CD8 double positive to CD8 single positive thymo-
cyte transition may be more easily modulated by the
weakened CD8a-b interface interaction noted here.
The structure of the CD8ab heterodimer reported
herein provides the first atomic view of CD8b subunit, re-
veals a remarkable similarity between CD8ab and CD8aa
structures, and supports the earlier hypothesis that
the CD8ab heterodimer binds to MHC class I molecules
in a similar manner to that of CD8aa. While CDR1 and
CDR2 of CD8b are different in composition and in confor-
mation from those of CD8a in both the homodimer or
heterodimer (Figures 2 and 3), these loops are similar in
being positively charged and complementary to the neg-
atively charged CD-loop of the a3 domain of the Kb
mouse MHCI molecule (Figure 4). Furthermore, the rigid
and conformationally similar CDR3 loops (FG-turn) of
both CD8a and CD8b (Figure 3) suggest that the center
of the ligand binding site may be largely in common and
represents an important determinant for MHCI binding.
We used site-directed mutagenesis to map those res-
idues of CD8ab that are critical for CD8ab coreceptor
function and to explore possible CD8ab binding modes
for pMHCI interaction. In addition, given that the CD8aa
homodimer binds Kb asymmetrically, certain residues
from one CD8a subunit are important for CD8aa function
while the same residues from the second CD8a subunit
are not. This asymmetry allowed us to knock out CD8aa
function while retaining CD8ab function and thus selec-
tively examine CD8ab coreceptor functions: from the
crystal structure of the CD8aa/Kb complex, it was ob-
served that the residue Arg8 from CD8a1 is critical to
CD8aa function while the Arg8 residue of CD8a2 makes
no atomic contacts with Kb (Kern et al., 1998). Since
CD8aR8Ab functions normally (Wong et al., 2003), we in-
fer that the CD8b subunit of the CD8aR8Ab should sit in
a position corresponding to the CD8a1 subunit during
its interaction with Kb. This orientation places CD8b on
the ‘‘top,’’ consistent with the CD8ab-MHC binding
model suggested by Kern et al. (1998). In this model,
the CD8a subunit is at the bottom and the interactionswith the CD-loop of the Kb a3 domain are therefore
mostly conserved, including the hydrogen bond be-
tween Gln226 on the CD-loop of Kb a3 domain and the
Ser37 from the CD8a subunit at the bottom.
To examine possible CD8b/Kb interactions, we have
generated a docking model by overlaying the CD8ab
structure onto the CD8aa/Kb complex with the CD8a
subunit of CD8ab superimposed on CD8a2 of CD8aa,
as shown in Figure 6C. In this model, both CDR2 and
CDR3 of CD8b can form interactions with Kb while
CDR1 is pointed away from the interaction interface.
This model is consistent with our mutagenesis results,
indicating that CDR2 and CDR3, but not CDR1, residues
of CD8b are critical to CD8ab MHC binding (Figure 5). In
comparison to the CDR2 of CD8a, the CDR2 of CD8b tilts
toward CDR3, offering the possibility of additional
atomic contacts with Kb. Mutational data on the CD8a
residue Asn107 also appear to support the CD8b-on-
top model. The side chain of Asn107 from CD8a1 forms
two hydrogen bonds to the main chain of the a3 domain
of Kb in the CD8aa/Kb complex structure. The same res-
idue from CD8a2 makes no direct Kb interaction. The
Asn107Ala substitution abolishes CD8aa homodimer
activity. However, CD8aN107Ab functions normally, as
does the triple mutant CD8aR8A/E27A/N107Ab. In the
CD8b-on-top model, the Ser101 of CD8b can potentially
form one hydrogen bond to a main chain amide of Kb,
partially compensating for the two hydrogen bonds in-
volving the CD8a Asn107 residue.
Although our data favor the CD8b-on-top model of
CD8ab/Kb interaction, the mutation data do not exclude
other possible CD8ab binding modes. Given the similar-
ity in shape and charge of CD8aa and CD8ab dimers,
more than one orientation might be possible. In the
CD8aa/Kb interaction, CD8a1 N-terminal residues Lys1,
Gln3, and Arg8 interact extensively with b2M residues.
In contrast, CD8b is six residues shorter at its N terminus
relative to CD8a, so in the CD8b-on-top model, there
might be fewer possible contacts between CD8b and
b2M. It remains to be determined whether there could
be any adjustment in conformation of b2M or subtle shift
in the CD8ab docking orientation relative to that of
CD8aa during CD8ab binding to Kb such that equivalent
interactions to b2M might be restored or compensated
through additional contacts.
There is at least one critical issue with the CD8b-on-
the-bottom model. In that orientation, Gln226 from the
CD-loop of Kb a3 domain would lose its hydrogen bond-
ing partner, Ser37 of CD8a2. The Ser37 of CD8a is re-
placed by Tyr32 in CD8b. As a result, the bulky phenol
ring of Tyr32 would make a collision in the highly
crowded environment, preventing the side chain of Kb
Gln226 from inserting into CD8b. Recall that this Tyr-
to-Ser substitution is conserved across species (Fig-
ure 2). If CD8ab does bind Kb with the CD8b subunit in
the bottom position, it will require a major adjustment
of the interaction mode relative to that observed in the
CD8aa/Kb complex.
It is noteworthy that we are unable to crystallize
scmCD8abL29 with Kb under any experimental condi-
tions tested to date, despite our ability to crystallize in-
dividual components alone as well as CD8aa/Kb and
CD8aa/TL complexes (Liu et al., 2003). An intriguing ex-
planation may be that more than one potential CD8ab
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tice formation impossible. We cannot exclude alterna-
tive possibilities including the potential for the flexible
linker between CD8a and CD8b Ig-like domains to
impede MHCI binding. The former possibility can be
eliminated by crystallization of mutants such as
CD8aR8A/E27A/N107Ab that show a defined binding orien-
tation.
A number of molecules are known to form homo-
dimers or heterdimers to fine-tune functional activities
as well as interaction specificities. For example, Max
can form a Max-Max homodimer or Myc-Max and
Mad-Max heterodimers, mediating different activities
in transcriptional activation, cellular transformation,
and apoptosis (Brownlie et al., 1997; Nair and Burley,
2003). IkBa and IkBb interact with NF-kB p65 homo-
dimers and NF-kB p50/p65 heterodimers to mediate dis-
tinct transcriptional regulatory function (Jacobs and
Harrison, 1998; Malek et al., 2003). In these situations,
each homo- or heterodimer defines a separate binding
mode at discrete target sites. To our knowledge, if
CD8ab has two distinct binding orientations at an essen-
tially identical site on the same ligand, this would be
unprecedented.
In summary, our study describes the structure of the
CD8ab headpiece at 2.4 A˚ resolution. In size, shape,
and surface electrostatic potential of CDRs, CD8ab
resembles CD8aa. Based on mutagenesis studies,
a model in which CD8b replaces the CD8a1 subunit in
binding to H2-Kb is suggested, but additional possibili-
ties exist. Analysis of T cell development and function
of CD8aR8A/E27A/N107Abwt transgenic mice should help
address whether this orientation is sufficient to rescue
normal T lineage differentiation and T cell activation in
CD8a knockout mice. In the future, the expression of
recombinant CD8aR8A/E27A/N107Abwt variant protein may
facilitate structural studies of the CD8ab/pMHCI com-
plex as well.
Experimental Procedures
Protein Expression and Purification of scmCD8abL29
The N-terminal Ig-like domain of mCD8a (residues Lys1-Ser124) was
fused via a flexible linker of 29 amino acids (AGSADDARKDAARKD
DARKDDARKDGSSA) with the N-terminal Ig-like domain of mCD8b
chain (residues Leu1-Val115). The cDNA of the scmCD8abL29 was
cloned into the pEE14 vector and transfected into CHO-Lec 3.8.2.1
cells to express recombinant protein as previously described for
CD8ab-LZ proteins (Kern et al., 1998). A high-expressing clone
was selected, expanded, and cultured in FiberCell Hollow Fiber Car-
tridge (FiberCell Systems). The yield of scmCD8abL29 from 1 l of cell
supernatant wasw10 mg/l.
The protein was purified with anti-CD8a antibody (53-6.72)-affinity
chromatography. As proteins expressed in Lec 3.2.8.1 cells have
high mannose adducts exclusively in the N-linked glycosylation
sites, affinity-purified scmCD8abL29 protein was subjected to
Endo-H (Roche) digestion to remove N-linked glycans in an en-
zyme/substrate ratio of 0.02U Endo-H/1 mg protein at 37ºC over-
night in 50 mM NaOAc (pH 5.5) as described previously (Kern
et al., 1998). Concanavalin A Sepharose beads (Amersham Pharma-
cia) were used to deplete any residual nondeglycosylated CD8
protein by rotation at room temp for 2–4 hr. Subsequently, homoge-
nous, deglycosylated CD8 proteins (scmCD8abL29H) were recov-
ered by a final gel-filtration step with a Superdex S-200 column
(Amersham Pharmacia). The purified scmCD8abL29H protein in
10 mM HEPES (pH 7.4) was concentrated tow20 mg/ml for crystal-
lization.Crystallization and Data Collection
ScmCD8abL29H crystals were grown at room temperature from a so-
lution containing 25% PEG4000, 0.2 M (NH4)2SO4, 0.1 M Tris (pH 8.5)
with the vapor diffusion hanging drop method. The crystals were
then prefrozen for data collection with a cryoprotectant solution of
20% glycerol, 25% PEG4000, and 0.1 M Tris (pH 8.5). One diffraction
data set was obtained at 100ºK at the 19ID beam line of the Structure
Biology Center at the Advanced Photon Source, Argonne National
Laboratory. The data set was processed and reduced with
HKL2000 suite (Table 1; Otwinowski and Minor, 1997).
Structure Determination
The structure of mCD8abwas determined by molecular replacement
with the program Phaser within CCP4 suite (Table 1; Storoni et al.,
2004). A CD8a protomer from the CD8aa homodimer structure
(PDB code: 1BQH) was used as a search probe. The program found
positions of four monomers, which formed two CD8aa-like dimers
without clashes to each other. After careful examination of electron
density maps, two CD8b subunits were unambiguously assigned to
two of the four positions based on CD8a/CD8b sequences and their
alignment. These two CD8a and two CD8b subunits formed two
CD8ab heterodimers.
Model Building and Refinement
Model building, especially the CD8b and the loops of CD8a, was
manually performed with the programs XtalView (McRee, 1993)
and O (Jones et al., 1991). The structure was refined with the pro-
gram CNS (Brunger et al., 1998). The first three N-terminal residues
(Lys1-Pro-Glu) of both CD8a monomers of the CD8ab structures
were missing, with no electron densities. The C-terminal CD8a re-
gions were visible up to Lys121 in dimer A and to Val122 in dimer
B. A partial C-terminal linker (RKDGSSA), which is connected to
the N terminus of CD8b, was recognized and built into the model
for the dimer A. Only 2-residue partial linker for dimer B was seen.
There were density breaks at the BC-loops of both a and b subunits.
A part of the BC-loop (Lys27-Leu-Thr) of the CD8b subunit of dimer B
was truncated due to weak densities. The density for Pro102 of
CD8b at the FG-turn was not well defined. A cis-proline appeared
to be favored and was built into the model. There are in total six po-
tential N-linked glycosylation sites in two CD8ab dimers, two in each
CD8a and one in each CD8b. Based on electron densities, three
N-acetyl-glucosamine (NAG) residues were built into the model,
attaching to the Asn42 of CD8a of the dimer A, the Asn42 of CD8a,
and Asn13 of CD8b of the dimer B, respectively. The final model
also includes 44 water molecules.
CD8a and CD8b Variant Constructs
To generate the double mutation CD8aR8A/E27A variant, mouse
CD8aR8A was subjected to mutagenesis with a PCR method as de-
scribed previously (Wong et al., 2003). An additional single mutation
was added to the cDNA of CD8aR8A/E27A to create the following triple
mutation CD8a variants: CD8aR8A/E27A/S106A, CD8aR8A/E27A/N107A,
CD8aR8A/E27A/S108A, and CD8aR8A/E27A/V109A. The same strategy
was used to generate the following CD8b variants: CDR1 loop resi-
dues (bK23A, bS24A, bI25A, bS26A, bK27A, bL28A, and bT29A), CDR2 loop
residues (CD8bS53A, bS54A, bK55A, bG56A, and bV57A), and CDR3 loop
residues (bS101A, bP102A, and bK103A).
N15 Transfectants Expressing CD8 Variants and IL-2 Production
To generate the cell line expressing double mutant CD8aR8A/E27A, the
mutant CD8a cDNA was transfected alone or with wild-type CD8b
into the N15CD82 cell line as described previously (Witte et al.,
1999). For the cell lines expressing CD8aR8Abvar heterodimers, the
mutant CD8aR8A cDNA was transfected pair-wise with each CD8b
variant cDNA from the CDR1, CDR2, and CDR3 loops into the
N15CD82 cell line. The resulting transfectants were tested for sur-
face expression of TCRb chain, CD8a and CD8b (by anti-CD8b
mAb YTS156) before combining and sorting of bulk populations
for similar surface expression levels of CD8. The IL-2 production
of the CD8-expressing N15 transfectants was quantified with the
MTT assay (Wong et al., 2003).
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Supplemental Data include one figure and can be found with this
article online at http://www.immunity.com/cgi/content/full/23/6/
661/DC1/.
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